Trials / Not Yet Recruiting
Not Yet RecruitingNCT07288411
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
Pilot Study of the Effects of Transcutaneous Non-Invasive Vagus Nerve Stimulation (nVNS) on Symptoms and Brain Mechanisms in Premenopausal Women With Temporomandibular Disorders (TMD)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Arpana Church · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to examine the effects of transcutaneous non-invasive vagus nerve stimulation (nVNS) on symptoms and brain mechanisms in premenopausal women with temporomandibular disorders (TMD). Non-invasive vagus nerve stimulation (nVNS) is the most well researched and possibly the most effective non-invasive neuromodulation treatment for chronic pain conditions that targets the brain-gut-microbiome (BGM) axis. Participants will be asked to come in for 2 in-clinic visits, at baseline and post treatment. Participants will also be asked to come in 2x/week for 8 consecutive weeks to receive the nVNS treatment. The in-clinic visits will include physical measures, blood draw, saliva sample, and brain MRI. Participants will be asked to collect a stool sample at home and answer online questionnaires regarding, mood, pain, and health behaviors at home, prior to the in-clinic appointments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | nVNS Treatment | nVNS treatment 2x/week for 8 consecutive weeks. |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-12-17
- Last updated
- 2026-03-17
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07288411. Inclusion in this directory is not an endorsement.